4-Hydroxythiobenzamide is a key pharmaceutical intermediate primarily used in the synthesis of febuxostat (a xanthine oxidase inhibitor for gout treatment). This compound features a melting point of 181-185°C and predicted boiling point of 320.4±44.0°C at 760 mmHg, with a density of 1.338±0.06 g/cm³. The thiobenzamide structure enables versatile transformations in medicinal chemistry. Storage should be in airtight containers under inert atmosphere at room temperature, protected from light. Safety precautions include wearing protective gloves/eyewear due to potential skin/eye irritation (GHS Category 2).
